{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:41:56Z","timestamp":1787640116159,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015846","name":"Llywodraeth Cymru","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C8225\/A21133"],"award-info":[{"award-number":["C8225\/A21133"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012360","name":"Heart of England NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.canep.2023.102337","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T15:03:39Z","timestamp":1676300619000},"page":"102337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England"],"prefix":"10.1016","volume":"83","author":[{"given":"Melissa Ruth","family":"Gannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2563-4910","authenticated-orcid":false,"given":"Min Hae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-9980","authenticated-orcid":false,"given":"Katie","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-1777","authenticated-orcid":false,"given":"Kieran","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-4409","authenticated-orcid":false,"given":"Karen","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibby","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Alan","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2023.102337_bib1","unstructured":"NICE, Early and locally advanced breast cancer: diagnosis and management.2018. www.nice.org.uk\/guidance\/ng101."},{"key":"10.1016\/j.canep.2023.102337_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.2055","article-title":"Factors associated with age disparities among cancer clinical trial participants","author":"Ludmir","year":"2019","journal-title":"JAMA Oncol."},{"issue":"27","key":"10.1016\/j.canep.2023.102337_bib3","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.canep.2023.102337_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2020.11.003","article-title":"Assessing new drugs in advanced cancer: beyond randomised evidence","volume":"33","author":"Dodwell","year":"2021","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"1","key":"10.1016\/j.canep.2023.102337_bib5","article-title":"Data resource profile: the systemic anti-cancer therapy (SACT) dataset","volume":"49","author":"Bright","year":"2020","journal-title":"Int J. Epidemiol."},{"issue":"9","key":"10.1016\/j.canep.2023.102337_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S1470-2045(16)30383-7","article-title":"30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study","volume":"17","author":"Wallington","year":"2016","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.canep.2023.102337_bib7","doi-asserted-by":"crossref","DOI":"10.2217\/fon-2019-0669","article-title":"Consistency of recording of chemotherapy cycles in the National Cancer Registration and Analysis Service Systemic Anti-Cancer Therapy database and the Hospital Episode Statistics Admitted Patient Care database","volume":"16","author":"McDonald","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.canep.2023.102337_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2021.101971","article-title":"Validity of chemotherapy information derived from routinely collected healthcare data: a national cohort study of colon cancer patients","volume":"73","author":"Boyle","year":"2021","journal-title":"Cancer Epidemiol."},{"issue":"4","key":"10.1016\/j.canep.2023.102337_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyx015","article-title":"Data resource profile: hospital episode statistics admitted patient care (HES APC).","volume":"46","author":"Herbert","year":"2017","journal-title":"Int J. Epidemiol."},{"key":"10.1016\/j.canep.2023.102337_bib10","doi-asserted-by":"crossref","first-page":"m4237","DOI":"10.1136\/bmj.m4237","article-title":"Treatment variation in early breast cancer in the UK","volume":"371","author":"Dodwell","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.canep.2023.102337_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2020.01.005","article-title":"Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England","volume":"11","author":"Gannon","year":"2020","journal-title":"J. Geriatr. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2023.102337_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41416-018-0090-1","article-title":"Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group","volume":"119","author":"Derks","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2023.102337_bib13","unstructured":"National audit of Breast Cancer in Older Patients (NABCOP). NABCOP , 2022. Annual Report2022 12\/05\/2022. https:\/\/www.nabcop.org.uk\/reports\/nabcop-2022-annual-report\/."},{"issue":"5","key":"10.1016\/j.canep.2023.102337_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/bjs.6930","article-title":"Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score","volume":"97","author":"Armitage","year":"2010","journal-title":"Br. J. Surg."},{"issue":"5","key":"10.1016\/j.canep.2023.102337_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035395","article-title":"Construction of the secondary care administrative records frailty (SCARF) index and validation on older women with operable invasive breast cancer in England and Wales: a cohort study","volume":"10","author":"Jauhari","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.canep.2023.102337_bib16","unstructured":"National Cancer Registration and Analysis Service. Matching SACT to Cancer Waiting Times Data (2014). http:\/\/www.ncin.org.uk\/publications\/data_briefings\/sact_cwt."},{"key":"10.1016\/j.canep.2023.102337_bib17","unstructured":"Health and Social Care Information Centre. Chemotherapy Regimens Clinical Coding Standards and Guidance OPCS-4 (2014). http:\/\/www.nwisinformationstandards.wales.nhs.uk\/sitesplus\/documents\/299\/ChemoRegClinCodStanGuidOPCS-4v1.0.pdf."},{"key":"10.1016\/j.canep.2023.102337_bib18","unstructured":"Health and Social Care Information Centre. Chemotherapy Regimens Clinical Coding Standards and Guidance OPCS-4 April 2017 (2017)."},{"issue":"10","key":"10.1016\/j.canep.2023.102337_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-018-0028-7","article-title":"Sociodemographic variation in the use of chemotherapy and radiotherapy in patients with stage IV lung, oesophageal, stomach and pancreatic cancer: evidence from population-based data in England during 2013-2014","volume":"118","author":"Henson","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2023.102337_bib20","unstructured":"All-Party Parliamentary Group on Breast Cancer, A Mixed Picture: an Inquiry into Geographical Inequalities and Breast Cancer (2018). https:\/\/breastcancernow.org\/sites\/default\/files\/appgbc_a_mixed_picture.pdf."},{"issue":"8476","key":"10.1016\/j.canep.2023.102337_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2023.102337_bib22","article-title":"Cancer treatment data in central cancer registries: when are supplemental data needed?","volume":"21","author":"Bradley","year":"2022","journal-title":"Cancer Inf."},{"issue":"4","key":"10.1016\/j.canep.2023.102337_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00005650-200004000-00008","article-title":"Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment","volume":"38","author":"Cooper","year":"2000","journal-title":"Med. Care"},{"issue":"9","key":"10.1016\/j.canep.2023.102337_bib24","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","article-title":"Comparison of SEER treatment data with medicare claims","volume":"54","author":"Noone","year":"2016","journal-title":"Med. Care"},{"issue":"8 Suppl","key":"10.1016\/j.canep.2023.102337_bib25","first-page":"55","article-title":"Utility of the SEER-Medicare data to identify chemotherapy use","volume":"40","author":"Warren","year":"2002","journal-title":"Med. Care"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782123000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782123000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:31:14Z","timestamp":1761802274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782123000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":25,"alternative-id":["S1877782123000176"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2023.102337","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2023.102337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102337"}}